Memphasys: Results of General Meeting
Filed with ASX · · 2 pages · English
Earlier from Memphasys
- Felix Registration Achieved in Vietnam and Cartridge Order
- Pivotal Felix Study Receives First Scientific Presentation
- European Commercial Roll-out continues with Poland Agreement
- Exclusive Thailand Commercialisation Agreement Secured
- UK Market Entry & Acceleration of Commercial Expansion
Later from Memphasys
- Felix Early Thai FDA Approval, Commercial Launch Accelerates
- Appendix 4E and 2026 Annual Report
- Appendix 4G and Corporate Governance Statement
- EUR526,500 Nordic Agreement Expands Felix European Footprint
- Notification of cessation of securities - MEM
Follow Memphasys into a list and get an email when it puts out news.
Follow Memphasys